Sartorius Stedim Biotech Aktie
192,85EUR | -1,20EUR | -0,62% |
WKN DE: A2AJKS / ISIN: FR0013154002
Sartorius Stedim Biotech Outperform
NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für Sartorius Stedim Biotech auf "Outperform" mit einem Kursziel von 250 Euro belassen. Ein starkes Geschäft mit Verbrauchsmaterialien habe Sartorius Stedim geholfen, schrieb Analyst Charles Weston in einer ersten Reaktion am Mittwoch. Die Profitabilität von Sartorius Stedim untermauere den guten Ausblick des Mutterkonzerns Sartorius./bek/mis
Veröffentlichung der Original-Studie: 16.04.2025 / 01:59 / EDT
Erstmalige Weitergabe der Original-Studie: 16.04.2025 / 01:59 / EDT
Hinweis: Informationen zur Offenlegungspflicht bei Interessenkonflikten im Sinne von § 85 Abs. 1 WpHG, Art. 20 VO (EU) 596/2014 für das genannte Analysten-Haus finden Sie unter http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
Zusammenfassung: Sartorius Stedim Biotech Outperform | ||
---|---|---|
Unternehmen: Sartorius Stedim Biotech |
Analyst: RBC Capital Markets |
Kursziel: 250,00 € |
Rating jetzt: Outperform |
Kurs*: 171,30 € |
Abst. Kursziel*: 45,94% |
Rating update: Outperform |
Kurs aktuell: 192,85 € |
Abst. Kursziel aktuell: 29,63% |
Analyst Name:: Charles Weston |
KGV*: - |
Nachrichten zu Sartorius Stedim Biotechmehr Nachrichten
16.04.25 |
ANALYSE-FLASH: RBC belässt Sartorius Stedim Biotech auf 'Outperform' (dpa-AFX) | |
16.04.25 |
Sartorius Stedim Biotech publishes unaudited first quarter results for 2025 (EQS Group) | |
15.04.25 |
Ausblick: Sartorius Stedim Biotech vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
01.04.25 |
Erste Schätzungen: Sartorius Stedim Biotech stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
25.03.25 |
Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. (EQS Group) | |
17.02.25 |
Sartorius Stedim Biotech releases Universal Registration Document 2024 (EQS Group) | |
07.02.25 |
Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting (EQS Group) | |
28.01.25 |
Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024 (EQS Group) |
Analysen zu Sartorius Stedim Biotechmehr Analysen
25.04.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
23.04.25 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
16.04.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
16.04.25 | Sartorius Stedim Biotech Market-Perform | Bernstein Research | |
16.04.25 | Sartorius Stedim Biotech Outperform | RBC Capital Markets |
Aktien in diesem Artikel
Sartorius Stedim Biotech | 192,85 | -0,62% |
|
Aktuelle Aktienanalysen
17:04 | Stellantis Sector Perform | RBC Capital Markets | |
16:41 | Carl Zeiss Meditec Halten | DZ BANK | |
15:56 | Heidelberg Materials Overweight | JP Morgan Chase & Co. | |
14:48 | Salesforce Overweight | JP Morgan Chase & Co. | |
13:42 | Stellantis Market-Perform | Bernstein Research | |
13:36 | UniCredit Overweight | JP Morgan Chase & Co. | |
13:31 | UniCredit Buy | Jefferies & Company Inc. | |
13:31 | Intesa Sanpaolo Buy | Jefferies & Company Inc. | |
13:27 | Sanofi Buy | Jefferies & Company Inc. | |
11:50 | Airbus Buy | Jefferies & Company Inc. | |
11:50 | MTU Aero Engines Buy | Jefferies & Company Inc. | |
11:34 | SAFRAN Buy | Jefferies & Company Inc. | |
10:44 | thyssenkrupp Hold | Deutsche Bank AG | |
10:16 | SUSS MicroTec Buy | Deutsche Bank AG | |
10:08 | Nordex Buy | Deutsche Bank AG | |
10:08 | Bilfinger Buy | Deutsche Bank AG | |
09:38 | Aroundtown Neutral | UBS AG | |
09:36 | Nagarro Buy | Warburg Research | |
09:33 | DO accumulate | Erste Group Bank | |
09:28 | STMicroelectronics Buy | UBS AG | |
09:27 | Infineon Buy | UBS AG | |
08:55 | Aroundtown Buy | Warburg Research | |
08:53 | Aroundtown Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08:52 | Aroundtown Underperform | Jefferies & Company Inc. | |
08:51 | Aroundtown Add | Baader Bank | |
08:03 | E.ON Outperform | Bernstein Research | |
07:57 | Mercedes-Benz Group Overweight | JP Morgan Chase & Co. | |
07:57 | BMW Overweight | JP Morgan Chase & Co. | |
07:51 | Richemont Buy | UBS AG | |
07:49 | Roche Buy | UBS AG | |
07:48 | Apple Neutral | UBS AG | |
07:17 | BAT Buy | UBS AG | |
07:16 | Salesforce Neutral | UBS AG | |
07:15 | Roche Underweight | JP Morgan Chase & Co. | |
07:14 | National Grid Sector Perform | RBC Capital Markets | |
06:59 | GFT Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
06:59 | Volkswagen Neutral | JP Morgan Chase & Co. | |
06:37 | Rheinmetall Buy | UBS AG | |
06:37 | Rheinmetall Buy | UBS AG | |
06:37 | easyJet Buy | UBS AG | |
06:30 | L'Oréal Underweight | JP Morgan Chase & Co. | |
27.05.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
27.05.25 | BASF Outperform | Bernstein Research | |
27.05.25 | Air Liquide Outperform | Bernstein Research | |
27.05.25 | Linde Outperform | Bernstein Research | |
27.05.25 | BAT Neutral | JP Morgan Chase & Co. | |
27.05.25 | Salesforce Overweight | JP Morgan Chase & Co. | |
27.05.25 | Salesforce Outperform | RBC Capital Markets | |
27.05.25 | International Consolidated Airlines Outperform | RBC Capital Markets | |
27.05.25 | RENK Buy | Jefferies & Company Inc. |